Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06307171
Status:
RECRUITING
Last Update Posted:
2024-03-12
First Post:
2024-03-05
Brief Title:
Human Leishmaniasis Antigen Recognition Pattern and Study of New Potential Biomarkers
Sponsor:
IRCCS Sacro Cuore Don Calabria di Negrar
Organization:
IRCCS Sacro Cuore Don Calabria di Negrar
Study Overview
Official Title:
Human Leishmaniasis Antigen Recognition Pattern and Study of New Potential Biomarkers
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LeishmARPs
Brief Summary:
This is an exploratory experimental multicentre study on archived serum samples and on prospectively collected serum samples and blood samples
General objectives of the study are to identify specific biomarkers in order to develop more accurate serological tests for the screening of Leishmania infections that does not present cross-reaction with other infectious diseases to unveil the Antigen Recognition Patterns ARPs of Leishmania infection in humans to verify whether the ARPs and the new biomarkers are common to different Leishmania infantum strains isolated in Italy as well as in other part of the World and to different strains of L donovani isolated in Sudan as well as in other part of the World and discard any possible cross reaction with other infectious diseases such as Chagas TB leprosy or malaria
General objectives of the study are to identify specific biomarkers in order to develop more accurate serological tests for the screening of Leishmania infections that does not present cross-reaction with other infectious diseases to unveil the Antigen Recognition Patterns ARPs of Leishmania infection in humans to verify whether the ARPs and the new biomarkers are common to different Leishmania infantum strains isolated in Italy as well as in other part of the World and to different strains of L donovani isolated in Sudan as well as in other part of the World and discard any possible cross reaction with other infectious diseases such as Chagas TB leprosy or malaria
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None